Patients with HFpEF have substantial exercise intolerance, which may be due to peripheral factors.
Abdominal aortic aneurysms are likely to be encountered in the primary care setting, making appropriate diagnosis and management indispensable.
PAH associated with CHD is linked to significant reductions in survival and quality of life, especially for patients progressing to Eisenmenger syndrome.
Antoine N. Saliba, MD, and colleagues summarized current literature surrounding the frequent complications that bring patients with thalassemia into the ED.
Although pulmonary hypertension as a result of interstitial lung disease is linked to significant morbidity and mortality, there is no consensus regarding screening or management of the disease.
Physicians should frame treatment options by their “harms and benefits,” not by their “risks and benefits.”
Skeletal muscle alterations in rheumatoid arthritis are often overlooked despite their important role in disability and cardiometabolic disease development.
Only 65.2% of adults surveyed in United States in 2014 reported that they consistently get at least 7 hours of sleep each night.
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
A substantial body of research points to a multifaceted link between depression and cardiovascular disease, with rates of depression being 3 times higher in patients with CAD.